Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2003
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320589A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320383A2 Photosensitisers
06/25/2003EP1320357A1 Topical polymeric antimicrobial emulsion
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP1019036B1 Use of d-methionine to reduce the toxicity of ototoxic drugs and noise
06/25/2003EP1014927B1 Use of shogaols and gingerols for preparing deodorant compositions
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0802783B1 Topical preparations containing l-arginine
06/25/2003CN1426419A Pharmaceutical compositions containing oligosaccharides and preparation thereof
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426305A Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1426300A Urea-containing gel preparation
06/25/2003CN1425691A Acetyl mannan and its preparing method and use
06/25/2003CN1425460A External use macleaya cordata tincture for curing skin pruritus
06/25/2003CN1425450A Skin scream for treating intractable dermatosis
06/25/2003CN1425442A Wound fast heeling medicine
06/25/2003CN1425439A Medicinal composition with beauty function and its preparing method
06/25/2003CN1425403A Ointment for curing leukoplakia vulvae and its preparing method
06/25/2003CN1425402A Curing medicine for wound
06/25/2003CN1425401A Medicine for curing foot and skin itch
06/25/2003CN1425390A Composition for burn and scald
06/25/2003CN1112213C Medicine for treating skin disease and its preparing method
06/25/2003CN1112212C Medicine liquid for treating pain of injury
06/25/2003CN1112199C Exterior applied medicine for treating dermatopathy
06/25/2003CN1112192C Exterior-applied medicine for treating scald and its preparing method
06/25/2003CN1112176C Fermented horse milk cream preparation
06/25/2003CN1112172C Shampoo for stopping baldness, growing hair, blackening hair and relieving itching
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583184 Topical compositions; plant extract
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583162 Chronic dermal ulcers, wound healing
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6582709 Composition for topical application for the treatment of skin disorders and skin diseases, comprising 1-6 wt. % Dead Sea Mud as an active ingredient. Said composition is for use in treating skin disorders and skin diseases such as psoriasis,
06/24/2003US6582695 The use of sphingomyelinase to increase the levels of skin and mucosal ceramides, as well as dermatological and cosmetic compositions containing same which are suitable for topical application are disclosed.
06/24/2003US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds
06/24/2003US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2130805C Use of mannose phosphates for the treatment of fibrotic disorders
06/24/2003CA2087251C Pharmaceutical compositions
06/21/2003CA2414343A1 Film forming liquid composition
06/19/2003WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049774A1 Transdermal transport of compounds
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049769A2 Method for reducing acne or improving skin tone
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049728A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049716A1 Stable topical formulation of clarithromycin
06/19/2003WO2003049715A2 Talc-containing cosmetic cleansing emulsion
06/19/2003WO2003049709A1 Ceramide emulsions
06/19/2003WO2003049708A1 Oil-in-water emulsion containing hydrophobic pigment dispersed and use thereof
06/19/2003WO2003049707A1 Oil-in-water emulsion containing water-swellable clay mineral and use thereof
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049660A1 Oxygen producing device for woundcare
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2001091696A8 Use of biguanide derivatives for making a medicine having a wound healing effect
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114525 Method of treating autoimmune diseases
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114514 Preventing collagen-based leukocyte adhesion and leukocyte adhesion
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114455 Sexual disorders
1 ... 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 ... 1065